Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Transcriptional signature primes human oral mucosa for rapid wound healing.

Iglesias-Bartolome R, Uchiyama A, Molinolo AA, Abusleme L, Brooks SR, Callejas-Valera JL, Edwards D, Doci C, Asselin-Labat ML, Onaitis MW, Moutsopoulos NM, Gutkind JS, Morasso MI.

Sci Transl Med. 2018 Jul 25;10(451). pii: eaap8798. doi: 10.1126/scitranslmed.aap8798.

PMID:
30045979
2.

Video-assisted thoracoscopic surgery versus robot-assisted thoracoscopic surgery versus thoracotomy for early-stage lung cancer.

Upham TC, Onaitis MW.

J Thorac Cardiovasc Surg. 2018 Jul;156(1):365-368. doi: 10.1016/j.jtcvs.2018.02.064. Epub 2018 Mar 2. No abstract available.

PMID:
29921098
3.

Minimally Invasive Lung Cancer Surgery Performed by Thoracic Surgeons as Effective as Thoracotomy.

Boffa DJ, Kosinski AS, Furnary AP, Kim S, Onaitis MW, Tong BC, Cowper PA, Hoag JR, Jacobs JP, Wright CD, Putnam JB Jr, Fernandez FG.

J Clin Oncol. 2018 Aug 10;36(23):2378-2385. doi: 10.1200/JCO.2018.77.8977. Epub 2018 May 23.

PMID:
29791289
4.

Prediction of Long-Term Survival After Lung Cancer Surgery for Elderly Patients in The Society of Thoracic Surgeons General Thoracic Surgery Database.

Onaitis MW, Furnary AP, Kosinski AS, Kim S, Boffa D, Tong BC, Cowper P, Jacobs JP, Wright CD, Putnam JB Jr, Fernandez FG.

Ann Thorac Surg. 2018 Jan;105(1):309-316. doi: 10.1016/j.athoracsur.2017.06.071. Epub 2017 Nov 22.

PMID:
29174391
5.

High-LET Radiation Increases Tumor Progression in a K-Ras-Driven Model of Lung Adenocarcinoma.

Asselin-Labat ML, Rampersad R, Xu X, Ritchie ME, Michalski J, Huang L, Onaitis MW.

Radiat Res. 2017 Nov;188(5):562-570. doi: 10.1667/RR14794.1. Epub 2017 Sep 27.

PMID:
28952911
6.

Improved Survival of Stage I Non-Small Cell Lung Cancer: A VA Central Cancer Registry Analysis.

Boyer MJ, Williams CD, Harpole DH, Onaitis MW, Kelley MJ, Salama JK.

J Thorac Oncol. 2017 Dec;12(12):1814-1823. doi: 10.1016/j.jtho.2017.09.1952. Epub 2017 Sep 23.

PMID:
28951090
7.

Sox2 expression in Schwann cells inhibits myelination in vivo and induces influx of macrophages to the nerve.

Roberts SL, Dun XP, Doddrell RDS, Mindos T, Drake LK, Onaitis MW, Florio F, Quattrini A, Lloyd AC, D'Antonio M, Parkinson DB.

Development. 2017 Sep 1;144(17):3114-3125. doi: 10.1242/dev.150656. Epub 2017 Jul 25.

8.

Minimally Invasive Thoracic Surgery 3.0: Lessons Learned From the History of Lung Cancer Surgery.

Cheng X, Onaitis MW, D'amico TA, Chen H.

Ann Surg. 2018 Jan;267(1):37-38. doi: 10.1097/SLA.0000000000002405. Review. No abstract available.

PMID:
28692471
9.

Surgically Managed Clinical Stage IIIA-Clinical N2 Lung Cancer in The Society of Thoracic Surgeons Database.

Boffa D, Fernandez FG, Kim S, Kosinski A, Onaitis MW, Cowper P, Jacobs JP, Wright CD, Putnam JB, Furnary AP.

Ann Thorac Surg. 2017 Aug;104(2):395-403. doi: 10.1016/j.athoracsur.2017.02.031. Epub 2017 May 17.

10.

Inactivation of ABL kinases suppresses non-small cell lung cancer metastasis.

Gu JJ, Rouse C, Xu X, Wang J, Onaitis MW, Pendergast AM.

JCI Insight. 2016 Dec 22;1(21):e89647. doi: 10.1172/jci.insight.89647.

11.

The Society of Thoracic Surgeons General Thoracic Surgery Database: 2016 Update on Research.

Gaissert HA, Fernandez FG, Allen MS, Burfeind WR, Block MI, Donahue JM, Mitchell JD, Schipper PH, Onaitis MW, Kosinski AS, Jacobs JP, Shahian DM, Kozower BD, Edwards FH, Conrad EA, Patterson GA.

Ann Thorac Surg. 2016 Nov;102(5):1444-1451. doi: 10.1016/j.athoracsur.2016.09.014. Review.

PMID:
27772572
12.

A Risk Score to Assist Selecting Lobectomy Versus Sublobar Resection for Early Stage Non-Small Cell Lung Cancer.

Gulack BC, Yang CJ, Speicher PJ, Yerokun BA, Tong BC, Onaitis MW, D'Amico TA, Harpole DH Jr, Hartwig MG, Berry MF.

Ann Thorac Surg. 2016 Dec;102(6):1814-1820. doi: 10.1016/j.athoracsur.2016.06.032. Epub 2016 Sep 1.

13.

Toxicity of definitive and post-operative radiation following ipilimumab in non-small cell lung cancer.

Boyer MJ, Gu L, Wang X, Kelsey CR, Yoo DS, Onaitis MW, Dunphy FR, Crawford J, Ready NE, Salama JK.

Lung Cancer. 2016 Aug;98:76-78. doi: 10.1016/j.lungcan.2016.05.014. Epub 2016 May 25.

PMID:
27393510
14.

Surgery versus stereotactic body radiation therapy for operable stage I non-small cell lung cancer: Can we achieve equipoise?

Onaitis MW, Salama J.

J Thorac Cardiovasc Surg. 2016 Jul;152(1):1-2. doi: 10.1016/j.jtcvs.2016.04.016. Epub 2016 Apr 19. No abstract available.

15.

Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Population-Based Analysis.

Yerokun BA, Sun Z, Yang CJ, Gulack BC, Speicher PJ, Adam MA, D'Amico TA, Onaitis MW, Harpole DH, Berry MF, Hartwig MG.

Ann Thorac Surg. 2016 Aug;102(2):416-23. doi: 10.1016/j.athoracsur.2016.02.078. Epub 2016 May 4.

16.

Longitudinal Follow-up of Lung Cancer Resection From the Society of Thoracic Surgeons General Thoracic Surgery Database in Patients 65 Years and Older.

Fernandez FG, Furnary AP, Kosinski AS, Onaitis MW, Kim S, Boffa D, Cowper P, Jacobs JP, Wright CD, Putnam JB Jr.

Ann Thorac Surg. 2016 Jun;101(6):2067-76. doi: 10.1016/j.athoracsur.2016.03.034. Epub 2016 May 5.

PMID:
27157052
17.

Polymorphisms of the centrosomal gene (FGFR1OP) and lung cancer risk: a meta-analysis of 14,463 cases and 44,188 controls.

Kang X, Liu H, Onaitis MW, Liu Z, Owzar K, Han Y, Su L, Wei Y, Hung RJ, Brhane Y, McLaughlin J, Brennan P, Bickeböller H, Rosenberger A, Houlston RS, Caporaso N, Landi MT, Heinrich J, Risch A, Wu X, Ye Y, Christiani DC, Amos CI, Wei Q; Transdisciplinary Research in Cancer of the Lung (TRICL) Research Team.

Carcinogenesis. 2016 Mar;37(3):280-289. doi: 10.1093/carcin/bgw014. Epub 2016 Feb 10.

18.

Use and Outcomes of Minimally Invasive Lobectomy for Stage I Non-Small Cell Lung Cancer in the National Cancer Data Base.

Yang CF, Sun Z, Speicher PJ, Saud SM, Gulack BC, Hartwig MG, Harpole DH Jr, Onaitis MW, Tong BC, D'Amico TA, Berry MF.

Ann Thorac Surg. 2016 Mar;101(3):1037-42. doi: 10.1016/j.athoracsur.2015.11.018. Epub 2016 Jan 26.

19.

Role of Adjuvant Therapy in a Population-Based Cohort of Patients With Early-Stage Small-Cell Lung Cancer.

Yang CF, Chan DY, Speicher PJ, Gulack BC, Wang X, Hartwig MG, Onaitis MW, Tong BC, D'Amico TA, Berry MF, Harpole DH.

J Clin Oncol. 2016 Apr 1;34(10):1057-64. doi: 10.1200/JCO.2015.63.8171. Epub 2016 Jan 19.

20.

Long-term survival following open versus thoracoscopic lobectomy after preoperative chemotherapy for non-small cell lung cancer.

Yang CF, Meyerhoff RR, Mayne NR, Singhapricha T, Toomey CB, Speicher PJ, Hartwig MG, Tong BC, Onaitis MW, Harpole DH Jr, D'Amico TA, Berry MF.

Eur J Cardiothorac Surg. 2016 Jun;49(6):1615-23. doi: 10.1093/ejcts/ezv428. Epub 2015 Dec 30.

21.

Impact of patient selection and treatment strategies on outcomes after lobectomy for biopsy-proven stage IIIA pN2 non-small cell lung cancer.

Yang CF, Adil SM, Anderson KL, Meyerhoff RR, Turley RS, Hartwig MG, Harpole DH Jr, Tong BC, Onaitis MW, D'Amico TA, Berry MF.

Eur J Cardiothorac Surg. 2016 Jun;49(6):1607-13. doi: 10.1093/ejcts/ezv431. Epub 2015 Dec 30.

22.

Benign emptying of the postpneumonectomy space.

Kara HV, Mallipeddi MK, Javidfar J, Onaitis MW.

Lung India. 2015 Nov-Dec;32(6):614-5. doi: 10.4103/0970-2113.168136.

23.

Modern Management of Pulmonary Metastases.

Onaitis MW, D'Amico TA.

Thorac Surg Clin. 2016 Feb;26(1):xi. doi: 10.1016/j.thorsurg.2015.10.001. No abstract available.

PMID:
26611517
24.

Comparison Between the 2007 and 2014 American College of Cardiology/American Heart Association Guidelines on Perioperative Evaluation for Noncardiac Surgery.

Oprea AD, Fontes ML, Onaitis MW, Kertai MD.

J Cardiothorac Vasc Anesth. 2015 Dec;29(6):1639-50. doi: 10.1053/j.jvca.2015.04.021. Epub 2015 Apr 28. Review. No abstract available.

PMID:
26341877
25.

Adding radiation to induction chemotherapy does not improve survival of patients with operable clinical N2 non-small cell lung cancer.

Yang CF, Gulack BC, Gu L, Speicher PJ, Wang X, Harpole DH, Onaitis MW, D'Amico TA, Berry MF, Hartwig MG.

J Thorac Cardiovasc Surg. 2015 Dec;150(6):1484-92; discussion 1492-3. doi: 10.1016/j.jtcvs.2015.06.062. Epub 2015 Jul 2.

26.

Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer.

Berry MF, Yang CJ, Hartwig MG, Tong BC, Harpole DH, D'Amico TA, Onaitis MW.

Ann Thorac Surg. 2015 Jul;100(1):271-6. doi: 10.1016/j.athoracsur.2015.02.076. Epub 2015 May 16.

27.

Adjuvant chemotherapy after resection of N1 non-small cell lung cancer: differential impact of new evidence on physician and patient decisions.

Coleman BK, Curtis LH, Onaitis MW, D'Amico TA, Berry MF.

J Thorac Dis. 2015 Mar;7(3):243-51. doi: 10.3978/j.issn.2072-1439.2015.01.42.

28.

Defining the role of adjuvant chemotherapy after lobectomy for typical bronchopulmonary carcinoid tumors.

Nussbaum DP, Speicher PJ, Gulack BC, Hartwig MG, Onaitis MW, D'Amico TA, Berry MF.

Ann Thorac Surg. 2015 Feb;99(2):428-34. doi: 10.1016/j.athoracsur.2014.08.030. Epub 2014 Dec 10.

PMID:
25499480
29.

Adjuvant chemotherapy is associated with improved survival after esophagectomy without induction therapy for node-positive adenocarcinoma.

Speicher PJ, Englum BR, Ganapathi AM, Mulvihill MS, Hartwig MG, Onaitis MW, D'Amico TA, Berry MF.

J Thorac Oncol. 2015 Jan;10(1):181-8. doi: 10.1097/JTO.0000000000000384.

30.
31.

The cell of origin and subtype of K-Ras-induced lung tumors are modified by Notch and Sox2.

Xu X, Huang L, Futtner C, Schwab B, Rampersad RR, Lu Y, Sporn TA, Hogan BL, Onaitis MW.

Genes Dev. 2014 Sep 1;28(17):1929-39. doi: 10.1101/gad.243717.114.

32.

Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer.

Speicher PJ, Ganapathi AM, Englum BR, Hartwig MG, Onaitis MW, D'Amico TA, Berry MF.

J Thorac Oncol. 2014 Aug;9(8):1195-201. doi: 10.1097/JTO.0000000000000228.

33.

Thoracoscopic left upper lobectomy in patients with internal mammary artery coronary bypass grafts.

Shah AA, Worni M, Onaitis MW, Balderson SS, Harpole DH, D'Amico TA, Berry MF.

Ann Thorac Surg. 2014 Oct;98(4):1207-12. doi: 10.1016/j.athoracsur.2014.05.068. Epub 2014 Aug 7.

34.

Use of amiodarone after major lung resection.

Berry MF, D'Amico TA, Onaitis MW.

Ann Thorac Surg. 2014 Oct;98(4):1199-206. doi: 10.1016/j.athoracsur.2014.05.038. Epub 2014 Aug 5.

35.

Outcomes after treatment of 17,378 patients with locally advanced (T3N0-2) non-small-cell lung cancer.

Speicher PJ, Englum BR, Ganapathi AM, Onaitis MW, D'Amico TA, Berry MF.

Eur J Cardiothorac Surg. 2015 Apr;47(4):636-41. doi: 10.1093/ejcts/ezu270. Epub 2014 Jul 8.

36.

Outcomes after pneumonectomy for benign disease: the impact of urgent resection.

Klapper J, Hirji S, Hartwig MG, D'Amico TA, Harpole DH, Onaitis MW, Berry MF.

J Am Coll Surg. 2014 Sep;219(3):518-24. doi: 10.1016/j.jamcollsurg.2014.01.062. Epub 2014 Apr 8.

37.

Thoracoscopic approach to lobectomy for lung cancer does not compromise oncologic efficacy.

Berry MF, D'Amico TA, Onaitis MW, Kelsey CR.

Ann Thorac Surg. 2014 Jul;98(1):197-202. doi: 10.1016/j.athoracsur.2014.03.018. Epub 2014 May 10.

38.

Robotic benign esophageal procedures.

Hanna JM, Onaitis MW.

Thorac Surg Clin. 2014 May;24(2):223-9, vii. doi: 10.1016/j.thorsurg.2014.02.004. Review.

PMID:
24780427
39.

Thoracoscopic lobectomy is associated with acceptable morbidity and mortality in patients with predicted postoperative forced expiratory volume in 1 second or diffusing capacity for carbon monoxide less than 40% of normal.

Burt BM, Kosinski AS, Shrager JB, Onaitis MW, Weigel T.

J Thorac Cardiovasc Surg. 2014 Jul;148(1):19-28, dicussion 28-29.e1. doi: 10.1016/j.jtcvs.2014.03.007. Epub 2014 Mar 13.

40.

Sex differences in early outcomes after lung cancer resection: analysis of the Society of Thoracic Surgeons General Thoracic Database.

Tong BC, Kosinski AS, Burfeind WR Jr, Onaitis MW, Berry MF, Harpole DH Jr, D'Amico TA.

J Thorac Cardiovasc Surg. 2014 Jul;148(1):13-8. doi: 10.1016/j.jtcvs.2014.03.012. Epub 2014 Mar 14.

41.

Survival in the elderly after pneumonectomy for early-stage non-small cell lung cancer: a comparison with nonoperative management.

Speicher PJ, Ganapathi AM, Englum BR, Onaitis MW, D'Amico TA, Berry MF.

J Am Coll Surg. 2014 Mar;218(3):439-49. doi: 10.1016/j.jamcollsurg.2013.12.005. Epub 2013 Dec 12.

42.

Fewer complications result from a video-assisted approach to anatomic resection of clinical stage I lung cancer.

Boffa DJ, Dhamija A, Kosinski AS, Kim AW, Detterbeck FC, Mitchell JD, Onaitis MW, Paul S.

J Thorac Cardiovasc Surg. 2014 Aug;148(2):637-43. doi: 10.1016/j.jtcvs.2013.12.045. Epub 2014 Jan 15.

43.

Differential prognostic significance of extralobar and intralobar nodal metastases in patients with surgically resected stage II non-small cell lung cancer.

Haney JC, Hanna JM, Berry MF, Harpole DH, D'Amico TA, Tong BC, Onaitis MW.

J Thorac Cardiovasc Surg. 2014 Apr;147(4):1164-8. doi: 10.1016/j.jtcvs.2013.12.015. Epub 2014 Jan 2.

44.

The contemporary role of minimally invasive esophagectomy in esophageal cancer.

Mallipeddi MK, Onaitis MW.

Curr Oncol Rep. 2014 Mar;16(3):374. doi: 10.1007/s11912-013-0374-9. Review.

PMID:
24488547
45.

Sleeve lobectomy for non-small cell lung cancer with N1 nodal disease does not compromise survival.

Berry MF, Worni M, Wang X, Harpole DH, D'Amico TA, Onaitis MW.

Ann Thorac Surg. 2014 Jan;97(1):230-5. doi: 10.1016/j.athoracsur.2013.09.016. Epub 2013 Nov 6.

46.

Cell of origin of lung cancer.

Hanna JM, Onaitis MW.

J Carcinog. 2013 Mar 16;12:6. doi: 10.4103/1477-3163.109033. Print 2013.

47.

Does pneumonectomy have a role in the treatment of stage IIIA non-small cell lung cancer?

Shah AA, Worni M, Kelsey CR, Onaitis MW, D'Amico TA, Berry MF.

Ann Thorac Surg. 2013 May;95(5):1700-7. doi: 10.1016/j.athoracsur.2013.02.044. Epub 2013 Mar 29.

48.

Sox2 cooperates with inflammation-mediated Stat3 activation in the malignant transformation of foregut basal progenitor cells.

Liu K, Jiang M, Lu Y, Chen H, Sun J, Wu S, Ku WY, Nakagawa H, Kita Y, Natsugoe S, Peters JH, Rustgi A, Onaitis MW, Kiernan A, Chen X, Que J.

Cell Stem Cell. 2013 Mar 7;12(3):304-15. doi: 10.1016/j.stem.2013.01.007.

49.

Impact of T status and N status on perioperative outcomes after thoracoscopic lobectomy for lung cancer.

Villamizar NR, Darrabie M, Hanna J, Onaitis MW, Tong BC, D'Amico TA, Berry MF.

J Thorac Cardiovasc Surg. 2013 Feb;145(2):514-20; discussion 520-1. doi: 10.1016/j.jtcvs.2012.10.039. Epub 2012 Nov 21.

50.

Thoracoscopic lobectomy has increasing benefit in patients with poor pulmonary function: a Society of Thoracic Surgeons Database analysis.

Ceppa DP, Kosinski AS, Berry MF, Tong BC, Harpole DH, Mitchell JD, D'Amico TA, Onaitis MW.

Ann Surg. 2012 Sep;256(3):487-93. doi: 10.1097/SLA.0b013e318265819c.

Supplemental Content

Loading ...
Support Center